Biohaven
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 3 days.
- Recent price momentum is +10.2% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 9.9% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 02:27 UTC
Data coverage: 4 of 6 factors. Missing data is not a zero score.
The radar needs all six factors. Available grades are shown below.
Valuation N/A
How expensive the stock is versus earnings, sales and its own 5-year history.
Not enough data to grade this factor.
Growth N/A
How fast revenue, profit and free cash flow are compounding.
Not enough data to grade this factor.
Profitability F
How much profit the business keeps from each dollar of sales and capital.
| Return on equity | -310.8% | Better than 2% |
| Return on invested capital | -185.5% | Better than 1% |
Momentum B+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -10.5% | Better than 50% |
| 6-month return | 31.1% | Better than 90% |
| 12-month return (ex latest month) | 43.2% | Better than 80% |
| Distance below 52-week high | 32.1% | Better than 39% |
Financial Health C
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 3.2x | Better than 75% |
| Debt to assets | 63.0% | Better than 7% |
Analyst View A-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 72.7% | Better than 50% |
| Upside to average target | 130.6% | Better than 88% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 13.65
- Open
- 13.26
- Day range
- 12.31 - 13.75
- Avg price
- 12.68
- Volume
- 2.39M
- Turnover
- 30.37M
- Turnover ratei
- 2.05%
- Volume ratioi
- 1.16
- Amplitudei
- 10.55%
- 52-week rangei
- 8.03 - 18.24
Valuation
- P/Ei
- -1.81
- P/E (TTM)i
- -3.29
- P/Bi
- -19.06
- EPSi
- -6.86
- Book value / shi
- -0.65
- Net profit
- -1.04B
- Net assets
- -98.19M
Share structure
- Market cap
- 1.87B
- Float capi
- 1.44B
- Shares out
- 151.06M
- Float sharesi
- 116.57M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2017-05-04
32.1% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-20.40M net over the window
Short interest
- Shares short
- 15.01M
- % of floati
- 9.94%
- Days to coveri
- 2.94
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Biohaven (BHVN)?
Biohaven last traded at 12.39. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Biohaven's market cap?
About 1.87B.
What is the P/E ratio of Biohaven?
The trailing twelve-month P/E is -3.29. The Valuation tab shows it against the stock's own five-year range.
Does Biohaven pay a dividend?
Biohaven does not currently pay a regular dividend.
Is Biohaven a buy according to analysts?
The consensus of 11 analysts is a Buy rating, with an average 12-month price target of 28.57, which implies 130.6% upside from the current price. This is not investment advice.
What is Biohaven's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Biohaven a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 20:01:17 · For reference only, not investment advice and not tailored to your situation.
Biohaven discussion 0 comments